Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of HUG186 FDC vs Loose Combination in Healthy Volunteers
NCT03475719Phase 1Unknown
- Sponsor
- Huons
- Start
- Jan 2018
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bazedoxifene and vitamin d in postmenopausal osteoporosis (2 arms), sponsored by Huons. Primary endpoints: Area Under the Curve from time 0 to last measurable concentration for Bazedoxifene at 120 hours, Maximum Plasma Concentration for Bazedoxifene at 120 hours and 2 more. Status: unknown.
02
Drugs
bazedoxifenevitamin d
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT03475719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03475719.